Evidence map›Paper›PMID 39073841›Full record

ArticleFuture medicinal chemistry2024

Fluorinated building blocks in drug design: new pathways and targets.

Oleksandr O Grygorenko, Kostiantyn P Melnykov

Abstract readEditorial
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Direct Regioselective para-Fluorination via I(I)/I(III) Catalysis.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Pd/C-Catalyzed Hydrogenation of CFAngewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. Article
  5. Deoxyfluorination of Hydroxy-Substituted Boronates.ACS organic & inorganic Au · 2026
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Oleksandr O GrygorenkoEnamine Ltd. (www.enamine.net), Winston Churchill Street 78, Kyïv, 02094, Ukraine.ORCID 0000-0002-6036-5859
Kostiantyn P MelnykovEnamine Ltd. (www.enamine.net), Winston Churchill Street 78, Kyïv, 02094, Ukraine.ORCID 0009-0003-6522-681X

Funding

EnamineMinistry of Education and Science of Ukraine 0122U001962 (22BF037-02)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug DesignHalogenationHumansbuilding blocksdrug discoveryfluorinefluoroalkylnovel chemotypesorganofluorine compounds

Identifiers

PMID39073841
PMCPMC11352780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.